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Open Forum Infectious Diseases
MAJOR ARTICLE
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Providence, Rhode Island, USA, 5John T. Milliken Department of Internal Medicine, School of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA, and 6Department of Population
Health Sciences, University of Mississippi Medical Center, Jackson, Mississippi, USA

Background. Disruptions in access to in-person human immunodeﬁciency virus (HIV) preventive care during the coronavirus
disease 2019 (COVID-19) pandemic may have a negative impact on our progress towards the Ending the HIV Epidemic goals in the
United States.
Methods. We used an agent-based model to simulate HIV transmission among Black/African American men who have sex
with men in Mississippi over 5 years to estimate how different reductions in access affected the number of undiagnosed HIV
cases, new pre-exposure prophylaxis (PrEP) starts, and HIV incidence.
Results. We found that each additional 25% decrease in HIV testing and PrEP initiation was associated with decrease of 20% in
the number of cases diagnosed and 23% in the number of new PrEP starts, leading to a 15% increase in HIV incidence from 2020 to
2022.
Conclusions. Unmet need for HIV testing and PrEP prescriptions during the COVID-19 pandemic may temporarily increase
HIV incidence in the years immediately after the disruption period.
Keywords. agent-based modeling; COVID-19; HIV testing; men who have sex with men; pre-exposure prophylaxis.
In 2019, the United States Department of Health and Human
Services announced the Ending the HIV Epidemic initiative
with the goal of ending the human immunodeﬁciency virus
(HIV) epidemic in the United States by 2030. This plan includes 4 primary strategies: diagnosing all individuals with
HIV infection, promoting rapid and consistent access to effective HIV treatment, preventing new HIV transmission events,
and responding to emerging outbreaks [1]. Although we have
made signiﬁcant strides towards the goals of this initiative,

Received 30 March 2022; editorial decision 20 May 2022; accepted 26 May 2022; published
online 6 June 2022
Correspondence: William C. Goedel, PhD, Brown University School of Public Health
Department of Epidemiology, 121 South Main Street, Box G-S121-2, Providence, Rhode
Island, 02912 (william_goedel@brown.edu).
Open Forum Infectious Diseases®
© The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases
Society of America. This is an Open Access article distributed under the terms of the
Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.
org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution
of the work, in any medium, provided the original work is not altered or transformed in
any way, and that the work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com
https://doi.org/10.1093/oﬁd/ofac274

the HIV epidemic in the United States continues, particularly
in the Deep South. According to recent data from the
Centers for Disease Control and Prevention in 2017, approximately half (49.6%) of the men who have sex with men
(MSM) in the United States who were diagnosed with HIV resided in the Southern United States [2]. Black/African
American MSM bear a disproportionate burden of the HIV
epidemic both in the country as a whole and in the South.
Among Black/African MSM diagnosed with HIV in 2017,
63% resided in the South [2]. These disparities are the culmination of a myriad of social and structural barriers to accessing
HIV testing and effective HIV prevention strategies such as
pre-exposure prophylaxis (PrEP), caused fundamentally by
structural and systemic racism; stigma, medical mistrust, and
lack of appropriate health insurance coverage are only a few examples of these barriers [3]. Given the signiﬁcant impact of the
HIV epidemic on Black/African American MSM in the United
States, the goals of the Ending the HIV Epidemic cannot be
achieved without addressing these inequities.
It is likely that the coronavirus disease 2019 (COVID-19)
pandemic has negatively impacted access to HIV prevention
COVID-19 Impacts on HIV Incidence • OFID • 1

Downloaded from https://academic.oup.com/ofid/article/9/7/ofac274/6603475 by Washington University in St. Louis user on 28 December 2022

Projected Effects of Disruptions to Human
Immunodeﬁciency Virus (HIV) Prevention Services
During the Coronavirus Disease 2019 Pandemic Among
Black/African American Men Who Have Sex With Men
in an Ending the HIV Epidemic Priority Jurisdiction

2 • OFID • Labs et al

setting to study the impact of the COVID-19 pandemic on
these outcomes among Black/African American MSM in the
United States because it is particularly affected by both pandemics [10–12].
METHODS
Study Design

We used TITAN, a previously described agent-based model
[13], to simulate HIV transmission among Black/African
American MSM in Jackson, Mississippi and to observe the effect of reduced clinical operations during the COVID-19 pandemic on the number of persons with undiagnosed HIV
infection, the number of persons newly initiating PrEP, and
HIV incidence. Agent-based modeling itself simulates interactions between individual entities, called agents, to generate
population-level outcomes using stochastic processes. We simulated a population of 6825 Black/African American MSM of
ages 18 to 64 between April 2020 and December 2025 with a
monthly discrete time-step. Using this study design, we estimated how changes in sexual behavior and disruption of inperson clinical practices affected HIV transmission, focusing
speciﬁcally on how many infections went undiagnosed over
the study period and how many at-risk individuals initiated
the use of PrEP relative to a counterfactual scenario where these
disruptions did not occur. Additional details regarding model
structure, parameterization, and calibration are included in
the Supplemental Appendix.
Patient Consent Statement

This study was deemed not to be human subjects research.
Data Sources

Model parameters are shown in Supplemental Table 1. Where
possible, we worked with primary data collected from the target
study population to parameterize the model. To parameterize
agent sexual behaviors, we conducted a secondary analysis of
baseline data from the Focus on the Future trial, a randomized
controlled trial of a brief, safer sex behavior promotion intervention conducted among young Black/African American
MSM in Mississippi [14]. To parameterize PrEP use behaviors
(eg, initiation, adherence, discontinuation), we conducted a
secondary analysis of data collected from an ongoing prospective cohort study of MSM initiating PrEP in Mississippi.
Initial HIV prevalence and progression along the continuum
of care was informed by HIV surveillance estimates from
the Mississippi State Department of Health [15]. Where required, we drew values for parameters from the published literature, prioritizing estimates from studies of Black/African
American MSM in Mississippi or the Southern United States.
If these values were unavailable, we used data from national
studies.

Downloaded from https://academic.oup.com/ofid/article/9/7/ofac274/6603475 by Washington University in St. Louis user on 28 December 2022

and treatment services and potentially exacerbated these
disparities. Beginning in March 2020, many clinical settings reduced in-person operations as a result of physical distancing
policies enacted to mitigate the spread of COVID-19, thereby
reducing access to healthcare in many communities. Several
studies have begun to assess how these restrictions may have affected access to HIV preventive services. In a nationwide survey
of HIV care providers, Brawley [4] found that 40.7% had only
prescribed reﬁlls for existing PrEP prescriptions and 4.8% had
not prescribed PrEP at all during “stay-at-home” orders. At one
clinical site in Boston, orders for HIV tests decreased by 85%,
the number of patients initiating PrEP decreased by 72%, and
the number of patients with lapses in PrEP prescription reﬁlls
increased by 191% during a stay-at-home order [5]. Surveys
of PrEP-using MSM in the Southern United States have shown
that many have foregone HIV testing and have experienced difﬁculties obtaining their PrEP prescriptions since the beginning
of the pandemic [6]. It is possible that changes in sexual risk behavior undergone during the pandemic may have mitigated
some of the effects of these lapses in PrEP coverage and initiation; however, collectively, these studies indicate that there
have been signiﬁcant interruptions in the provision of HIV prevention services, which may have left cases undiagnosed and
prevented MSM at risk for HIV infection from getting a prescription for PrEP.
Despite these preliminary studies, there are limited data on
the population-level impact of the COVID-19 pandemic on
HIV testing and PrEP outcomes among Black/African
American MSM in the United States. In light of this
empirical research gap, mathematical modeling studies have
begun to evaluate the short- and long-term impact of
COVID-19-related disruptions on access to HIV testing and
PrEP care among at-risk MSM. One recent study using a
network-based model of MSM in Atlanta found that reductions
in PrEP use during COVID-19 only had a moderate impact
on HIV incidence compared with reductions in use of HIV
treatment [7]. Although the stay-at-home orders in Atlanta
and other areas of the Southern United States are similar,
MSM living in more suburban and rural areas of the region
(and who have already faced signiﬁcant structural barriers to
accessing healthcare before the pandemic) may have been
more heavily impacted by these service disruptions [8, 9].
In this study, we aimed to assess the impact of clinical service
disruptions during the COVID-19 pandemic on progress towards the goals of the “Diagnose” and “Prevent” pillars of the
Ending the HIV Epidemic initiative among Black/African
American MSM in the Deep South using an agent-based network model. Our study speciﬁcally focuses on Black/African
America MSM in Jackson, Mississippi, because we sought to
understand how these service disruptions may have affected existing disparities and altered the trajectory of the HIV epidemic
in this community. Jackson, Mississippi was an appropriate

Model Description

Demography

The model population was estimated to be 6825 persons [16].
Agents either left the model by death at rates derived from
the National Vital Statistics System for Black/African
American men in Mississippi or by aging out at 65 [17].
These agents were replaced by new agents using distributions
of the initial population.

In our model, HIV transmission could occur through sexual
contact occurring between agents situated in sexual networks.
Under the assumption that that all agents could engage in sexual activity, a target number of sexual partners per year was assigned to each agent, drawn from a negative binomial
distribution (r = 12.5, P = .931) [14]. Based on data from the
Focus on the Future Trial, the number of anal sex acts per
month was assigned to each partnership from a Gamma distribution (k = 0.730, θ = 4.339) [14]. The probability of condom
use during anal sex was drawn from normal distribution
(mean = 0.403; standard deviation = 0.025).
Human Immunodeﬁciency Virus Transmission

We estimated the per-act probabilities of transmission for sexual risk behaviors through a recent meta-analysis [18]. We accounted for the increased infectiousness of acute HIV infection
by increasing the probability of transmission by a factor of 10
for a period of 3 months [19]. After this acute stage, agents experienced a chronic state of infection in which all agents with
HIV infection were subject to a probability of developing acquired immune deﬁciency syndrome that was determined by
engagement with HIV treatment.
Human Immunodeﬁciency Virus Prevention and Treatment
Engagement

The model population was initialized with an HIV prevalence of
48%, where 83% were assumed to be diagnosed, 69% were assumed to be using antiretroviral treatment (ART), and 50%
were assumed to be virally suppressed based on existing surveillance data [15]. Agents who became newly infected were subject
to monthly probabilities of being diagnosed, engaging with ART,
and achieving viral suppression. Agents who were not infected
with HIV or those who were infected but were unaware of their
HIV status were subject to a probability of obtaining HIV testing. Human immunodeﬁciency virus-negative agents initiated
PrEP with a probability of 0.049.
Model Scenarios

As a base case for comparison, we simulated a counterfactual scenario over a 5-year period from April 2020 to December 2025 to
simulate the “status quo” where levels of clinical service engagement are maintained in the absence of the COVID-19 pandemic

Model Calibration and Validation

The primary targets for model calibration were the number of
new HIV diagnoses from 2014 to 2019, which were obtained
COVID-19 Impacts on HIV Incidence • OFID • 3
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Sexual Networking

and its impacts. Because the model was calibrated using trends in
HIV diagnoses and treatment informed by the Mississippi State
Department of Health, we assumed a stable incidence rate of
HIV infections with an increasing percentage of cases treated
based on past trends in these outcomes. In addition, we assumed
increasing PrEP coverage over time based on data from the cohort. In all other scenarios, a stay-at-home order in Mississippi
was initiated by Executive Order 1463 and lasted from March
2020 to June 2020 [20]. Beyond this period, we accounted for a
single, 18-month period of clinical service disruption that began
in March 2020 and ended in September 2021 [21].
To estimate the longer-term effects of the stay-at-home orders
and subsequent reductions in in-person clinical operations on
missed diagnoses of HIV and initiation of PrEP, we simulated
the disruption of in-person clinical practice by reducing probabilities of HIV testing and PrEP initiation. Because the extent to
which HIV testing and PrEP initiation has been reduced during
the pandemic is unknown, we simulated scenarios that decreased
the probabilities of HIV testing and PrEP initiation by percentages
ranging from 0% to 75% in 25% increments (0%, 25%, 50%, and
75%). We classiﬁed these levels of disruption as corresponding to
the following real-world scenarios: no disruption to in-person
clinical practice (status quo), minimal levels of disruption (physical distancing and reduced access to some clinical operations
such as testing, 25%), moderate levels of disruption (partial shutdown of in-person clinics with more physical distancing restrictions, 50%), and severe levels of disruption (complete shutdown
of nonessential operations, 75%). Although the 75% can be viewed
as the “worst-case” scenario of the impact of disruption on inperson clinical visits, the 25% and 50% levels of disruption can
be seen as implicitly including the use of certain mobile health
(mHealth) interventions, such as the use of self-testing or telehealth appointments. Although there is little evidence on how
prevalent these technologies are among Black/African American
MSM in the Deep South, this uncertainty is accounted for in
the differing levels of disruption modeled. Additional mitigation
effects due to changes in sexual behavior are addressed in the sensitivity analysis. In our primary analysis, we simulated service disruptions lasting for 1 duration of 18 months.
The main measures of comparison in our study were the
number of new HIV infections, the absolute and relative changes in the number of new HIV diagnoses, and the absolute and
relative changes in the number of new PrEP starts over the
5-year study period (2020–2025). Comparing these values
among the model scenarios and the counterfactual scenario,
we were able to measure how in-person clinical disruptions affected HIV diagnosis, PrEP uptake, and underlying HIV incidence at the population level.

Table 1. Projected Values of Selected Population-Level Outcomes by Model Scenario Among Black/African American MSM in Mississippi, 2020 to 2022
Level of Disruption
Average Number of New Infections Per Year

Average Number of Diagnoses Per Year

2020
201.3 [149.5–256.1]

2022
198.7 [149.0–256.1]

25%

205.7 [151.5–262.0]

212.8 [152.0–267.0]

209.7 [155.0–273.1]

50%

210.9 [158.5–266.1]

228.3 [168.0–293.0]

221.6 [160.0–280.5]

75%

216.2 [160.5–281.0]

243.7 [180.0–314.5]

237.2 [172.0–311.1]

192.7 [159.5–231.5]

182.0 [147.5–222.6]

186.3 [156.0–220.5]
203.4 [164.0–242.0]

0% (baseline)
25%

156.2 [129.5–185.0]

156.9 [128.0– 191.0]

50%

117.2 [91.0–143.0]

116.5 [92.5–142.0]

221.7 [186.0–260.5]

75%

77.0 [57.5–96.0]

64.4 [47.5–82.0]

243.8 [202.0–291.1]

0% (baseline)
25%

Average PrEP Coverage Per Year

2021
198.8 [145.5–261.1]

49.9 [32.0–68.5]

49.5 [34.0–69.0]

50.3 [31.0–70.0]

38.6 [24.0–55.5]

39.1 [24.5–54.5]

50.4 [31.0–70.0]

50%

27.3 [16.0–41.0]

28.2 [16.0–41.0]

51.3 [34.0–70.0]

75%

15.1 [8.0–25.0]

15.9 [8.0–25.0]

52.1 [33.0–71.5]

26.8% [18.2%–38.5%]

26.8% [18.2%–38.8%]

26.8% [17.8%–38.6%]

25%

0% (baseline)

23.8% [15.1%–35.7%]

22.6% [14.7%–33.8%]

25.3% [17.8%–36.3%]

50%

20.6% [12.0%–32.8%]

17.8% [10.5%–28.9%]

23.5% [16.5%–3.4%]

75%

17.3% [9.3%–29.3%]

12.6% [6.8%–23.3%]

21.6% [14.9%–30.8%]

Abbreviations: PrEP, pre-exposure prophylaxis.

from the Mississippi State Department of Health [15]. We used
an indirect, iterative method with Latin hypercube sampling to
derive the subset of model runs that were the best ﬁt for the calibration target data. With this approach, we identiﬁed plausible
ranges for a set of parameters with the most uncertainty associated with their “true” values for the study population as their
initial estimates were drawn from other populations and generated 10 000 sets of parameters. After methods developed by
Zang et al [22], we calculated a goodness-of-ﬁt statistic for
each set of parameters and identiﬁed the sets of parameters
that generated outputs within 10% of the targets to use in subsequent analyses (Supplementary Figure 1, Supplemental
Table 2). During model validation, we used 500 best-ﬁtting
sets of parameters to project the trajectory of the local HIV epidemic for 12 months to assess the ability of the model to reproduce the number of new HIV diagnoses in 2019 as the primary
validation target.
Sensitivity Analyses

In our main analysis, we assumed no change in average number
of sexual partners during the service disruption period because
of the variability in ﬁndings surrounding this change among
MSM during the pandemic [23, 24]. In a sensitivity analysis,
we simulated scenarios in which agents were unable to acquire
new sexual partners, and the number of anal intercourse acts
per month was decreased by 50% during the period of the
stay-at-home order [20].
RESULTS

After calibrating the model and calculating the goodness-of-ﬁt
statistic for each set of parameters, we found that our calibrations matched well with our primary validation target of the
4 • OFID • Labs et al

number of HIV diagnoses in 2019 (Supplemental Figure 1).
In the counterfactual scenario, in which there was no disruption to in-person clinical practices, there were 1392 cumulative
new infections from 2019 to 2025 (95% simulation interval,
1026–1797) (Table 1), resulting in an annual average of 204
new infections in 2019 (95% simulation interval, 156.0–262.1)
that gradually lowered to 195.6 new infections in 2025 (95%
simulation interval, 139.4–255.0) (Figure 1). An average of
1312 newly diagnosed cases occurred during the study period
(1075–1566) with an annual average of 195.9 per year
(Figure 2). There were 50 new PrEP starts per year (31–71)
(Figure 3), yielding a ﬁnal PrEP coverage of 27% in 2025
(18%–39%) (Figure 4).
Across all scenarios simulating disruption to in-person clinical practices due to the COVID-19 pandemic, the total number
of new infections increased above the levels observed in the
counterfactual scenario (Figure 1), with these increases being
most pronounced through the period of service disruption
(March 2020 to September 2021). These increases in HIV incidence were evident into 2022 in scenarios with mild and moderate levels of disruption and into 2023 in a scenario with severe
levels of disruption (Figure 1).
Accordingly, the number and proportion of cases diagnosed
during 2020 and 2021 decreased in a manner directly proportional to the level of reduction in HIV testing activities
(Figure 2). After a return to prepandemic levels of service provision in late 2021, the number of HIV diagnoses was elevated
relative to the number observed in the counterfactual scenario
throughout the period from 2022 to 2025 due to the increases in
detection of excess cases that accumulated during the period of
service disruption (Figure 2).
By design, fewer agents began using PrEP during the period
of service disruption (Figure 3), leading to signiﬁcant decreases

Downloaded from https://academic.oup.com/ofid/article/9/7/ofac274/6603475 by Washington University in St. Louis user on 28 December 2022

Average Number of New PrEP Starts Per Year

0% (baseline)

Figure 2. Predicted annual number of new human immunodeﬁciency virus (HIV) diagnoses among Black/African American men who have sex with men in Mississippi under
conditions of varying levels of disruption in access to HIV prevention services, 2019 to 2025.
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Figure 1. Predicted annual number of new human immunodeﬁciency virus (HIV) infections among Black/African American men who have sex with men in Mississippi under
conditions of varying levels of disruption in access to HIV prevention services, 2019 to 2025.

Figure 4. Predicted population-level pre-exposure prophylaxis (PrEP) coverage among Black/African American men who have sex with men in Mississippi under conditions
of varying levels of disruption in access to human immunodeﬁciency virus prevention services, 2019 to 2025.
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Figure 3. Predicted annual number of pre-exposure prophylaxis (PrEP) initiation events among Black/African American men who have sex with men in Mississippi under
conditions of varying levels of disruption in access to human immunodeﬁciency virus prevention services, 2019 to 2025.

DISCUSSION

To our knowledge, this is among the ﬁrst studies to model how
reductions to in-person clinical practices impacted the number
of HIV cases diagnosed and access to PrEP among Black/
African American MSM in the Deep South. We found that disruption to in-person clinical practice is associated with a temporary increase in the number of new infections, a decrease in
the number of infections diagnosed, and a decrease in the percentage of cases diagnosed in the scenarios modeled. The results demonstrate that decreases in the number of HIV tests
ordered and conducted [4–6] may lead to small, temporary increases in HIV transmission owing to delays in diagnosis and
initiation of ART. Although the model predicts that many of
these epidemiological outcomes would return to the prepandemic levels beginning in 2023, even a moderate increase in
HIV incidence exacerbates an already unmet need for access
to HIV prevention and treatment among Black/African
American MSM.
To ensure that individuals who may have gone undiagnosed
during periods of reductions in clinical operations are linked to
proper care, HIV testing should be encouraged for those who
may have foregone regular HIV testing throughout the pandemic. Recent studies have suggested that Black/African
American MSM in Jackson experience more stigma and medical mistrust in access to HIV prevention and treatment [25].
Because medical mistrust has likely further increased during
the pandemic [26], particular attention should be devoted to
ensuring that members of this population are able to access
testing and be linked to prevention and treatment services in
care environments that acknowledge and actively work to
undo this mistrust.
To prevent further interruptions to our progress toward the
Ending the HIV Epidemic goals, disruptions to clinical activities related to testing, prescribing PrEP, and accessing care
should be avoided as much as possible. One way to achieve
this goal is to develop a robust telehealth infrastructure.
Rogers et al [27, 28] describe the beneﬁts of the implementation
of telemedicine at a lesbian, gay, bisexual, transgender and

queer or questioning (LGBTQ) health clinic in Rhode Island,
reporting high satisfaction from patients for this method of
HIV prevention and care. In the Southern United States, one
study provided further empirical evidence of the importance
of the use of telehealth services for HIV care in South
Carolina during the pandemic, but some of the participating
clinics did not have the capacity to implement the use of telehealth in a timely manner, resulting in further service disruption [29]. Cost reimbursement to providers of telehealth
and address so-called “digital poverty” such that all patients
have adequate technology to access it remain among the
chief structural barriers to scale-up of this approach [30].
Community-based telehealth kiosks have shown promise in expanding access to those who may have access to the technologies needed for these services [31]. More research must be
conducted on addressing disparities in access to telehealth services. Although there are current efforts to implement certain
telehealth and mobile health interventions within Mississippi
and the Deep South, there is little evidence about current trends
in telehealth use among MSM for PrEP services [32].
Nonetheless, the implementation of more telehealth practices
has the potential to prevent further and future disruptions to
clinical appointments and to connect more patients residing
in rural areas to high-quality clinics that may be in metropolitan areas.
At-home testing kits represent an additional resource for
mitigating the effects of disruptions to in-person clinical operations because several studies have shown that both patients
and providers perceived access to testing as much more limited
during the early pandemic months [5, 6]. A pilot program in
Oregon implemented during the pandemic found that offering
free, home-based testing for HIV during a period of physical
distancing helped to alleviate barriers and increased access to
testing [33]. Another study, based in Ottawa, demonstrated
that self-testing is a viable way to maintain access to HIV testing during pandemics [34]. Although these studies were not
based in the Southern United States, they offer evidence that
at-home testing kits could be a promising alternative to inperson testing if access was otherwise limited. More research
is needed on how to properly implement this intervention
and ensure that there are as few barriers to accessing the
at-home kits as possible and that individuals can be effectively
linked to care after a diagnosis.
There are several limitations that may be present in our analysis. First, in parameterizing the model, we attempted to use local data from Black/African American MSM in Jackson,
Mississippi as often as possible. However, not all the values
we used were derived from data sources speciﬁc to this population. Our method of model calibration may have alleviated
some of the uncertainty that these parameters may have introduced. There also may have been a nonaverage disruption, because we cannot say with certainty what the level of disruption
COVID-19 Impacts on HIV Incidence • OFID • 7
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in population-level PrEP coverage (Figure 4) in 2020 and 2021.
Under a scenario with the most severe levels of disruption,
population-level PrEP coverage is approximately halved,
from 26.8% (18.2%–38.8%) in the counterfactual scenario to
12.6% (6.8%–23.3%).
In our sensitivity analysis (Supplemental Figure 2), we found
that our results were robust against short-term changes in sexual behavior during the stay-at-home order from March 2020
to June 2020. Even when accounting for a potential decrease
in sexual risk behavior during the pandemic period, the number of new HIV infections increases signiﬁcantly above the base
scenario levels during the period of 2020 to 2022.

CONCLUSIONS

Our analysis predicts that disruptions to in-person clinical
practices during the COVID-19 pandemic may have caused a
temporary but meaningful increase in the number of new
HIV infections among Black/African American MSM in
Jackson, Mississippi. These disruptions and their implications
have likely hindered our progress toward the Ending the HIV
Epidemic goals in the short term. As in-person clinical
operations resume more typical levels, we must ensure that
those individuals who have undiagnosed infections are linked
to care as soon as possible. The implementation of a strong telehealth infrastructure for HIV prevention and care and
expanding the use of at-home testing kits could potentially
help prevent future periods of lower access, but more research
needs to be done on these interventions to address potential
inequities in access to these resources. Mitigating strategies
such as these could lead to disruption levels more akin to the
25% or no disruption levels, which would signiﬁcantly
improve HIV outcomes among Black/African American
MSM in the Deep South when compared with higher levels
of disruption.
Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases
online. Consisting of data provided by the authors to beneﬁt the reader, the
posted materials are not copyedited and are the sole responsibility of the
authors, so questions or comments should be addressed to the corresponding author.
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